Mirtazapine and Cabergoline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mirtazapine (mirtazapine) and Cabergoline (cabergoline). Common drug interactions include neutropenia among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Mirtazapine and Cabergoline. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Mirtazapine?

Mirtazapine has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 82,120 Mirtazapine users. Check the latest studies of Mirtazapine.

What is Cabergoline?

Cabergoline has active ingredients of cabergoline. It is often used in prolactinoma. eHealthMe is studying from 6,257 Cabergoline users. Check the latest studies of Cabergoline.

On Jul, 28, 2026

39 people who take Mirtazapine and Cabergoline together, and have interactions are studied.

Mirtazapine and Cabergoline drug interactions.

What are the common drug interactions of Mirtazapine and Cabergoline, by gender? *:

female:

Neutropenia (an abnormally low number of neutrophils)
Back pain
Diarrhoea
Dyslipidaemia (abnormal amount of lipids)
Leukopenia (less number of white blood cells in blood)
Type 2 diabetes mellitus
Urinary tract infection
Vulvovaginal candidiasis (vulvovaginal infection by fungi)
Abdominal pain
Chronic kidney disease

male:

Death
Drug ineffective
Emotional distress
Multiple fractures
Osteoporosis (bones weak and more likely to break)
Pain
Renal failure (kidney dysfunction)
Spinal fracture (fracture in one of vertebrae)
Tooth loss
Abnormal behaviour

What are the common drug interactions of Mirtazapine and Cabergoline, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Breast cancer female
Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Renal tubular necrosis (death of kidney tubules)
Breast cancer
Heart valve incompetence (heart's valves do not work correctly)

40-49:

Basophil count increased
Blood prolactin decreased
Blood thyroid stimulating hormone increased
Conjunctival haemorrhage (bleeding underneath the conjunctiva)
Corneal bleeding
Eosinophil count increased
Headache (pain in head)
Petechiae (a small red or purple spot caused by bleeding into the skin)
Pitting oedema (skin discoloration)
Thrombocytopenia (decrease of platelets in blood)

50-59:

Back pain
Diarrhoea
Dyslipidaemia (abnormal amount of lipids)
Leukopenia (less number of white blood cells in blood)
Neutropenia (an abnormally low number of neutrophils)
Type 2 diabetes mellitus
Urinary tract infection
Vulvovaginal candidiasis (vulvovaginal infection by fungi)
Abdominal pain
Chronic kidney disease

60+:

Death
Blood prolactin increased
Renal failure (kidney dysfunction)
Spinal fracture (fracture in one of vertebrae)
Tooth loss
Agitation (state of anxiety or nervous excitement)
Arthralgia (joint pain)
Blood creatinine increased
Chest discomfort
Chest pain

What are the existing conditions these people have? *

High Blood Pressure: 12 people, 30.77%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 20.51%
Hyperprolactinaemia (abnormally high levels of prolactin in the blood): 7 people, 17.95%
Type 2 Diabetes: 5 people, 12.82%
Prolactin-Producing Pituitary Tumor: 4 people, 10.26%
Parkinson's Disease: 4 people, 10.26%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 4 people, 10.26%
Psychotic Disorder: 4 people, 10.26%
Secondary Hypothyroidism (pituitary gland and its failure to secrete tsh): 4 people, 10.26%
Pituitary Tumor Benign: 3 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Mirtazapine and Cabergoline?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously